Dr. Chee Yang Chen

Dr. Chee Yang Chen is a medical doctor, investor, and entrepreneur with a mission to provide advanced genomic testing through his company Carta Genomics to help IVF parents predict their embryo's disease risk and health outcomes.

He holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) with Distinction in Medical Sciences and a Bachelor of Science with First Class Honours in Neuroscience from Imperial College London, where he also conducted groundbreaking research in cognitive development genes.

With over a decade of investing experience, Dr. Chen is dedicated to impact investing in emerging technologies that drive deep technological innovations to revolutionize traditional industries.

He is actively involved in various organizations, having served as Managing Director at Crossbow Capital, Medical Doctor at NHS, and Founder and CEO at Carta Genomics, among other roles.

Dr. Chen's diverse background includes being a Platoon Commander in the Singapore Armed Forces and leading the Asia-Pacific Region of the Young Investors Organisation, showcasing his commitment to making a positive impact on global health and technological advancements.